- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-small Cell Lung Cancer (NSCLC), Non-squamous
Total 7668 results
-
Theresa Whiteside, PhDImmune Cell Therapy Inc.TerminatedNon Small Cell Lung Cancer (NSCLC)United States
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Recombio SLEurofarma Laboratorios S.A.; Laboratorio Elea Phoenix S.A.; Innogene Kalbiotech... and other collaboratorsUnknownNSCLC | Lung Cancer, Non-small CellBrazil, Indonesia, Argentina, Cuba, Philippines, Singapore, Thailand
-
TTY BiopharmCompletedNon-small-cell Lung Cancer (NSCLC)Taiwan
-
AbbVie (prior sponsor, Abbott)CompletedNSCLC | Lung Cancer | Non-Small-Cell Lung CancerUnited States, Czech Republic, Greece, Hungary, Netherlands, Slovakia
-
National Taiwan University HospitalUnknownNon-small Cell Lung Cancer (NSCLC)Taiwan
-
PfizerTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
Dr Joanne CHIURecruitingALK Gene Rearrangement Positive | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Activating Mutation | Nsclc | ROS1 Gene Rearrangement | ROS1 Positive NSCLC - Reactive Oxygen Species 1 Positive Non-Small Cell Lung CancerHong Kong
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnUnspecified Adult Solid Tumor, Protocol Specific | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer
-
Incyte CorporationZai Lab (Shanghai) Co., Ltd.Active, not recruitingMetastatic Squamous Non-Small Cell Lung Cancer | Metastatic Nonsquamous Non-Small Cell Lung CancerChina, Czechia, Russian Federation, Serbia, Malaysia, Vietnam, United States, Poland, Ukraine, Romania, Turkey, Brazil, Bulgaria, Georgia, Hungary, Philippines, South Africa
-
AIO-Studien-gGmbHAstraZenecaRecruitingNSCLC | EGFR Positive Non-small Cell Lung Cancer | OligoprogressionGermany
-
National Taiwan University HospitalUnknownNon-small Cell Lung Cancer(NSCLC)Taiwan
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Healthy, no Evidence of Disease | Limited Stage Small Cell Lung... and other conditionsUnited States
-
Shanghai JMT-Bio Inc.Not yet recruitingSquamous Cell Non-small Cell Lung Cancer
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Promontory Therapeutics Inc.Pfizer; EMD SeronoCompletedNon-Small Cell Lung Cancer (NSCLC)United States, Switzerland
-
Centre Hospitalier Universitaire de NīmesMEDEXPRIM; GRATICULECompletedNon-small Cell Lung Cancer (NSCLC)France
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNon-small Cell Lung Cancer(NSCLC)China
-
Shanghai Yizhong Biotechnology Co., Ltd.UnknownNon-Small Cell Lung Cancer(NSCLC)China
-
Wake Forest University Health SciencesCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Ethicon Endo-SurgeryCompleted
-
Tang-Du HospitalActive, not recruitingNon-small-cell Lung Cancer (NSCLC)China
-
Ethicon Endo-SurgeryCompletedNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-squamous Non-small-cell LungPoland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerCanada, United States, Spain, Italy, France, United Kingdom
-
Shanghai Shengdi Pharmaceutical Co., LtdNot yet recruitingNon-squamous Non-small Cell Lung CancerChina
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerUnited States, Spain, China, France, Canada, Italy
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited States
-
Henan Cancer HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon-squamous Cell Non-Small Cell Lung CancerChina
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, China, Korea, Republic of, Canada, Japan, Netherlands, Italy
-
Sinocelltech Ltd.UnknownNon-squamous Cell Non-small Cell Lung Cancer
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
AmgenNot yet recruitingAdvanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced or Metastatic Non-squamous Non-small-cell Lung Cancer
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNon-Squamous Non-Small Cell Lung CancerChina
-
Erasca, Inc.CompletedAdvanced Non-squamous Non-small-cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance, Germany, Spain, Sweden, Russian Federation, Greece, Switzerland, Korea, Republic of, Italy, Netherlands, Turkey, United Arab Emirates
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBulgaria
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Spain, United Kingdom, Germany, Italy, Poland, France
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Hong Kong, Taiwan, Philippines, Thailand, Korea, Republic of, Indonesia
-
University Health Network, TorontoPfizerRecruitingNon-squamous Non-small-cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | ROS1 Gene Rearrangement | MET Activating Mutation | MET AmplificationCanada
-
Pulmonary Hospital ZakopaneRecruitingNon-Small Cell Lung Cancer (NSCLC) | Video Assisted Thoracic Surgery (VATS)Poland
-
VA Office of Research and DevelopmentNational Cancer Institute (NCI); Jonsson Comprehensive Cancer CenterTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
AstraZenecaCompleted
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung Cancer (NSCLC)United States, Brazil, Poland, Russian Federation, South Africa, France, Italy, United Kingdom